News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 433–468
- Matches
- 26877
- Sources here
- 13
- Companies here
- 34
Active search
26877 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Magnum Ice Cream to buy back shares worth €90 million
Magnum Ice Cream Company N.V. announced plans to repurchase up to 5.5 million shares through forward transactions. This buyback, valued at approximately €90 million, aims to fulfill obligations under its long-term incentive plans for employees. The company operates globally with a significant workforce and …
Share Purchase - Long Term Incentive Plans
The Magnum Ice Cream Company N.V. (TMICC) announced its intention to enter into forward transactions to acquire up to 5.5 million shares, valued at approximately €90 million at the current share price. These shares are intended to cover obligations arising from its long-term incentive …
Capricor Therapeutics, Inc. (NASDAQ:CAPR) Receives Average Rating of "Hold" from Brokerages
Capricor Therapeutics (NASDAQ:CAPR) has received an average "Hold" rating from eleven brokerages, with an average one-year price target of $29.15. Recent analyst adjustments include downgrades from "Buy" to "Hold" or "Neutral" by several firms, while one upgraded the stock to "Overweight." The company faces …
Guggenheim initiates Scribe Therapeutics stock with buy rating
Guggenheim has initiated coverage on Scribe Therapeutics Inc (NASDAQ:SCTX) with a buy rating and a price target of $50.00, suggesting significant upside potential from its current trading price of $21.19. The company is noted for its proprietary CRISPR platforms, XE and ELXR, which are …
Is Lululemon Athletica (LULU) Undervalued On Softer Guidance And A Split Fair Value View?
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Lululemon athletica (LULU) has come under closer investor focus after Q1 results paired an earnings beat with softer guidance that trailed apparel peers, followed by …
Sharemaestro market context Price below Trend Line 52 weeks -47.2% · Next-week setup negative 45.0%Renaissance Technologies LLC Sells 117,600 Shares of Northrim BanCorp Inc $NRIM
Renaissance Technologies LLC significantly reduced its stake in Northrim BanCorp Inc, selling 117,600 shares in the first quarter, decreasing its holding by 84.2%. Despite this, other institutional investors like Royal Bank of Canada, AQR Capital Management, and Goldman Sachs Group Inc. increased their positions. …
68,848 Shares in The Lovesac Company $LOVE Bought by GSA Capital Partners LLP
GSA Capital Partners LLP has acquired 68,848 shares of The Lovesac Company (NASDAQ:LOVE) valued at approximately $1.15 million, representing a 0.47% stake. This comes as hedge funds and institutional investors now collectively own 91.32% of LOVE, and company insiders have also been increasing their …
Quantinno Capital Management LP Buys Shares of 8,875 Nutex Health Inc. $NUTX
Quantinno Capital Management LP recently acquired 8,875 shares of Nutex Health Inc. (NASDAQ:NUTX) valued at approximately $843,000, establishing a 0.13% stake in the company. Institutional investors collectively own 5.32% of Nutex Health, which has a "Moderate Buy" consensus rating from analysts and an average …
REG - Smith & Nephew Plc - Director/PDMR Shareholding
Smith & Nephew Plc announced the vesting of Restricted Share awards from its 2024 plan on August 17, 2026. Following the vesting, shares were sold to cover tax obligations. CEO Deepak Nath was noted as a PDMR in a transaction involving 47,105 shares, with …
Old West Investment Management LLC Invests $5.05 Million in Thermo Fisher Scientific Inc. $TMO
Old West Investment Management LLC has acquired a new stake worth approximately $5.05 million in Thermo Fisher Scientific Inc. (NYSE:TMO) during the second quarter. Institutional investors now own 89.23% of the company, which maintains a "Moderate Buy" consensus rating from analysts with an average …
Global Retirement Partners LLC Purchases Shares of 23,627 Fifth Third Bancorp $FITB
Global Retirement Partners LLC recently acquired 23,627 shares of Fifth Third Bancorp (NASDAQ:FITB) for approximately $1,332,000 during the second quarter. Other institutional investors have also adjusted their holdings in the company. Analyst ratings for Fifth Third Bancorp are largely positive, with an average rating …
Global Retirement Partners LLC Invests $1.39 Million in Northrop Grumman Corporation $NOC
Global Retirement Partners LLC has acquired a new position in Northrop Grumman Corporation (NYSE:NOC), purchasing 2,725 shares valued at approximately $1.39 million. This investment comes amidst significant activity from other institutional investors, with several hedge funds increasing their holdings in the aerospace company. Northrop …
Global Retirement Partners LLC Takes $1.78 Million Position in The Travelers Companies, Inc. $TRV
Global Retirement Partners LLC has acquired a new stake of 5,389 shares, valued at $1.78 million, in The Travelers Companies, Inc. during the second quarter. This move comes as other institutional investors have also adjusted their positions in TRV, and analysts have set various …
Cornerstone Advisors LLC Acquires Shares of 7,864 Monolithic Power Systems, Inc. $MPWR
Cornerstone Advisors LLC has acquired 7,864 shares of Monolithic Power Systems, Inc. (NASDAQ:MPWR) during the second quarter, valued at approximately $10,871,000. Other institutional investors have also adjusted their positions in the semiconductor company. Insider transactions show EVP Maurice Sciammas and EVP Saria Tseng selling …
Deutsche Bank AG Invests $539.46 Million in The Boeing Company $BA
Deutsche Bank AG has acquired a new position in The Boeing Company, purchasing 2,492,058 shares valued at approximately $539.46 million in the second quarter, representing 0.32% ownership. Several other institutional investors also adjusted their holdings in Boeing. The article details Boeing's recent stock performance, …
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Given Average Rating of "Hold" by Analysts
Six research firms have given Akebia Therapeutics (NASDAQ:AKBA) an average rating of "Hold", with a consensus 12-month target price of $3.75. Recent analyst reports show mixed sentiment, including upgrades, downgrades, and reiterations of "buy" and "sell" ratings. The company recently reported better-than-expected earnings and …
AI in healthcare: Are you tracking the right competitors?
This article discusses how patent intelligence can reveal unexpected competitors in the rapidly evolving field of AI in healthcare. It highlights that medical technology companies are leading in AI-related patent filings, and relevant AI capabilities are emerging from diverse industries such as computing and …
Grandfield & Dodd LLC Purchases New Position in The Boeing Company $BA
Grandfield & Dodd LLC recently acquired a new position in The Boeing Company (NYSE:BA), purchasing 71,312 shares valued at approximately $15.437 million. This move is part of broader institutional interest, with several other firms also modifying their holdings in Boeing. Despite mixed analyst ratings …
HBK Sorce Advisory LLC Acquires Shares of 11,930 The TJX Companies, Inc. $TJX
HBK Sorce Advisory LLC has acquired a new position of 11,930 shares in The TJX Companies, Inc. (NYSE:TJX), valued at approximately $1.91 million. This acquisition is part of broader institutional investor activity, with several other hedge funds also adjusting their stakes in TJX Companies. …
Flputnam Investment Management Co. Purchases New Position in The TJX Companies, Inc. $TJX
Flputnam Investment Management Co. recently acquired a new position in The TJX Companies, Inc. (NYSE:TJX), purchasing 386,897 shares valued at approximately $58.6 million. This makes TJX Companies the 23rd largest holding for Flputnam, representing 0.7% of its portfolio. The article also details other institutional …
3,496,808 Shares in Phathom Pharmaceuticals, Inc. $PHAT Acquired by Carlyle Group Inc.
Carlyle Group Inc. has acquired a new stake of 3,496,808 shares in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) during the second quarter, valued at approximately $37.9 million, making PHAT its third-largest portfolio holding. Institutional investors collectively own 99.01% of the company's stock, with several firms increasing …
Deutsche Bank AG Takes $466.63 Million Position in CVS Health Corporation $CVS
Deutsche Bank AG has acquired a new position in CVS Health Corporation, purchasing over 4.5 million shares valued at approximately $466.63 million in the second quarter, representing about 0.35% of CVS Health. This move comes as other institutional investors have also adjusted their holdings …
North Media announces preliminary financial results for Q2 2026 and revises its full-year guidance for 2026
North Media A/S Announcement no. 10-2026 18 August 2026 Based on preliminary and unaudited figures, North Media's revenue for Q2 2026 was DKK 314m, a year-on-year decrease of 8%. The decrease was driven by an expected decline in printed matter and newspaper volumes in …
HBK Sorce Advisory LLC Buys Shares of 7,047 Thermo Fisher Scientific Inc. $TMO
HBK Sorce Advisory LLC recently purchased 7,047 shares of Thermo Fisher Scientific Inc. (NYSE:TMO) valued at approximately $4.07 million during the second quarter. Other institutional investors have also adjusted their holdings in the medical research company, which currently has a market capitalization of $216.90 …
Home Depot Earnings: HD Stock Rises after Q2 Beat and Guidance Reaffirmed
Home Depot reported second-quarter results that beat analyst expectations on both revenue and earnings Tuesday, though the company kept its full-year guidance unchanged rather than raising it. The Atlanta-based home improvement retailer recorded adjusted diluted earnings per share of $4.92, an improvement over the …
First Commonwealth Financial Corporation (NYSE:FCF) Receives Consensus Recommendation of "Moderate Buy" from Analysts
First Commonwealth Financial Corporation (NYSE:FCF) has received a consensus "Moderate Buy" rating from analysts, with an average 1-year price target of $24.25, surpassing its current stock price of $21.51. The company recently exceeded quarterly earnings expectations, reporting an EPS of $0.44 against an estimated …